{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:02:47Z","timestamp":1789437767889,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"DOI":"10.7759\/cureus.116243","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:36:37Z","timestamp":1789436197000},"source":"Crossref","is-referenced-by-count":0,"title":["Unexpected Pericardial Cytology in a Patient With Primary Squamous Cell Carcinoma of the Lung: Emphasizing the Need for Advanced Molecular Characterization of Tumors"],"prefix":"10.7759","author":[{"given":"Melinda","family":"Gevorgian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Minter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(85)80106-4","article-title":"Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases","volume":"16","author":"Roggli VL","year":"1985","unstructured":"Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol. 1985, 16:569-79. 10.1016\/s0046-8177(85)80106-4","journal-title":"Hum Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(92)90260-a","article-title":"Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance","volume":"23","author":"Brambilla E","year":"1992","unstructured":"Brambilla E, Moro D, Veale D, Brichon PY, Stoebner P, Paramelle B, Brambilla C. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol. 1992, 23:993-1003. 10.1016\/0046-8177(92)90260-a","journal-title":"Hum Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00058507","article-title":"Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis","volume":"31","author":"Moro-Sibilot D","year":"2008","unstructured":"Moro-Sibilot D, Lantuejoul S, Diab S, et al.. Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J. 2008, 31:854-9. 10.1183\/09031936.00058507","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst RS","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018, 553:446-54. 10.1038\/nature25183","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis WD","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, et al.. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015, 10:1243-60. 10.1097\/JTO.0000000000000630","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S164574","article-title":"Adenosquamous carcinoma of the lung","volume":"11","author":"Li C","year":"2018","unstructured":"Li C, Lu H. Adenosquamous carcinoma of the lung. Onco Targets Ther. 2018, 11:4829-35. 10.2147\/OTT.S164574","journal-title":"Onco Targets Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-024-00207-3","article-title":"Pericardial effusion in oncological patients: current knowledge and principles of management","volume":"10","author":"Mori S","year":"2024","unstructured":"Mori S, Bertamino M, Guerisoli L, et al.. Pericardial effusion in oncological patients: current knowledge and principles of management. Cardiooncology. 2024, 10:8. 10.1186\/s40959-024-00207-3","journal-title":"Cardiooncology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0659","article-title":"The eighth edition of TNM staging of lung cancer: reference chart and diagrams","volume":"23","author":"Lababede O","year":"2018","unstructured":"Lababede O, Meziane MA. The eighth edition of TNM staging of lung cancer: reference chart and diagrams. Oncologist. 2018, 23:844-8. 10.1634\/theoncologist.2017-0659","journal-title":"Oncologist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard D","year":"2018","unstructured":"Planchard D, Popat S, Kerr K, et al.. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018, 29:iv192-237. 10.1093\/annonc\/mdy275","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.6065","article-title":"Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"35","author":"Hanna N","year":"2017","unstructured":"Hanna N, Johnson D, Temin S, et al.. Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017, 35:3484-515. 10.1200\/JCO.2017.74.6065","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Riely GJ","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS, et al.. Non-small cell lung cancer, version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024, 22:249-74. 10.6004\/jnccn.2204.0023","journal-title":"J Natl Compr Canc Netw"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck M","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, et al.. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016, 375:1823-33. 10.1056\/NEJMoa1606774","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393786-unexpected-pericardial-cytology-in-a-patient-with-primary-squamous-cell-carcinoma-of-the-lung-emphasizing-the-need-for-advanced-molecular-characterization-of-tumors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:36:38Z","timestamp":1789436198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393786-unexpected-pericardial-cytology-in-a-patient-with-primary-squamous-cell-carcinoma-of-the-lung-emphasizing-the-need-for-advanced-molecular-characterization-of-tumors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.116243","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}